ZHENG Lili , ZHU Yujing , SHAO Caimei , ZHANG Yong . The Relationship between Cytochrome CYP3A4 in Vivo and the Toxicity of Aflatoxin B₁ in Feedstuffs[J]. Chinese Journal of Animal Nutrition, 2013 , 25(1) : 13 -20 . DOI: 10.3969/j.issn.1006-267x.2013.01.003

[1] GUENGERICH F P,WU Z L,BARTLESON C J.Function of human cytochrome P450s:characterization of the orphans[J].Biochemical and Biophysical Research Communications,2005,338(1):465-469.  
[2] YAO M,DAI M,LIU Z,et al.Comparison of the substrate kinetics of pig CYP3A29 with pig liver microsomes and human CYP3A4[J].Bioscience Reports,2011,31(3):211-220.  
[3] 王世春,桂蓓,商海涛,等.小型猪CYP3A88基因克隆与其他动物的序列比较[J].中国比较医学杂志,2009,19(1):15-20.
[4] SHEN H M,SHI C Y,SHEN Y,et al.Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1[J].Free Radical Biology and Medicine,1996,21(2):139-146.  
[5] KAMDEM L K,MEINEKE I,GODTEL-ARMBRUST U,et al.Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B₁[J].Chemical Research in Toxicology,2006,19:577-586.
[6] RIFFEL A K,SCHUENEMANN E,VYHLIDAL C A,et al.Regulation of the CYP3A4 and CYP3A7 promoters by members of the nuclear factor I transcription factor family[J].MolPharmaco,2009,76(5):1104-1114.
[7] DANIELSON P B.The cytochrome P450 superfamily:biochemistry,evolution and drug metabolism in humans[J].Current Drug Metabolism,2002,3(6):561-597.  
[8] YANO J K,WESTER M R,SCHOCH G A,et al.The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05A resolution[J].The Journal of Biological Chemistry,2004,279,(37):38091-38094.
[9] SCOTT E E,HALPERT J R.Structures of cytochrome P450 3A4[J].Trends in Biochemical Sciences,2005,30(1):5-7.  
[10] HASHIMOTO H,TOIDE K,KITARMURA R,et al.Gene structure of CYP3A4 an adult specific form of cytochrome P450 in human livers,and its transcriptional control[J].European Journal of Biochemisty,1993;218:355-366.
[11] 朱冰,周宏灏.CYP3A的分子机制研究进展[J].中国药理学通报,2000,16(6):614-617.
[12] LMBA J K,LIN Y S,SCHUETS E G,et al.Genetic contribution to variable human CYP3A-mediated metabolism[J].Advanced Drug Delivery Reviews,2002,54(10):1271-1294.  
[13] SATA F,SAPONE A,ELIZONDO G,et al.CYP3A4 allelic variants with amino acid substitutions in exon 7 and 12:evidence for an allelic variant with altered catalytic activity[J].Clinical Pharmacology & Therapeutics,2000,67:48-56.
[14] WATKINS R E,WISELY G B,MOORE L B,et al.The human nuclear xenobiotic receptor PXR:structural determinants of directed promiscuity[J].Science,2001,292(5525):2329-2333.  
[15] 穆殿平,徐为人,高仲阳.细胞色素P450 3A4基因多态性及对药物代谢的影响[J].中国药学杂志,2008,43(6):405-408.
[16] DIAZ K J,MURICAH W,CEPEDA S M.Bioactivation of aflatoxin B₁ by turkey liver microsomes:responsible cytochrome P450 enzymes[J].British Poultry Science,2010,51(6):828-837.  
[17] AKIYAMA T E,GONZALEZ F J.Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors[J].Biochimica et Biophysica Acta (BBA):General Subjects,2003,1619(3):223-234.  
[18] DENISSENKO M F,CAHILL J,KOUDRIAKOVA B.Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B₁-8,9-epoxide and microsomal activation systems[J].Mutation Research,1999,425(2):205-211.  
[19] KEN-ICHIRO M,AYAKO S,HARUKA W,et al.Electron paramagnetic resonance decay constant and oxidative stresses in liver microsomes of the selenium-deficient rat[J].The Journal of Nutritional Biochemistry,2006,17(10):677-681.  
[20] SURAI P F.Effect of selenium and vitamin E content of the maternal diet on the antioxidant system of the yolk and the developing chick[J].British Poultry Science,2000,41(2):235-243.  
[21] ATROSHI F,BIESE I,SALONIEMI H,et al.Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice[J].Canadian Society for Pharmaceutical Sciences,2000,3(3):281-291.
[22] CHOI Y K,JUNG K K,CHAE K Y,et al.Effects of vitamin E and selenium supplementation to diets containing aflatoxin B₁ on the contents of liver lipids and various blood parameters in rats[J].Australasian Journal of Animal Science,1995,8(4):379-385.
[23] RASTOGI R,SRICASTABA A K,RASTOGI A K.Long term effect of aflatoxin B₁ on lipid peroxidation in rat liver and kidney:effect of picroliv and silymarin[J].Phytotherapy Resesrch,2001,15(4):307-310.  
[24] DIAZ G J,MURICIA H W,CEPEDA S M,et al.The role of selected cytochrome P450 enzymes on the bioactivation of aflatoxin B₁ by duck liver microsomes[J].Avian Pathology,2010,39(4):279-285.  
[25] UENG Y F,SHIMADA T,YAMAZAKI H,et al.Oxidation of aflatoxin B₁ by bacterial recombinant human cytochrome P450 enzymes[J].Chemical Research Toxicology,1996,8(2):218-225.
[26] LYER R S,COLES BRIAN F,RANEY K D,et al.DNA adduction by the potent carcinogen aflatoxin B₁:mechanistic studies[J].Journal of the American Chemical Society,1994,116(5):1603-1609.  
[27] KRISHNAN R,RAGHUNATHAN R,MARU G B.Effect of polymeric black tea polyphenols on benzo(a)pyrene -induced cytochrome P4501A1 and 1A2 in mice[J].Xenobiotica,2005,35(7):671-682.  
[28] ABDEL-WAHHAB M A,HASSAN N S,EL-KADY A A,et al.Red ginseng extract protects against aflatoxin B₁ and fumonisins-induced hepatic pre-cancerous lesions in rats[J].Food and Chemical Toxicology,2010,48(2):733-742.  
[29] NAYAK S,SASHIDHAR R B.Metabolic intervention of aflatoxin B₁ toxicity by curcumin[J].Journal of Ethnopharmacology,2010,127(3):641-644.  
[30] KOHRLE J,ROLAND P,GARTNER M D.Selenium and thyroid[J].Best Practice & Research Clinical Endocrinology & Metabolism,2009,23(6):815-827.  
[31] ERKEKOGLU P,GIRAY B K,CAGLGYAN A,et al.Selenium and/or iodine deficiency alters hepatic xenobiotic metabolizing enzyme activities in rats[J].Journal of Trace Elements in Medicine and Biology,2012,26(1):36-41.  
[32] SINHA R,EI-BAYOUMY K.Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds[J].Current Cancer Drug Targets,2004,4(1):13-28.  
[33] El-BAYOUMY K,SINHA R.Molecular chemoprevention by selenium:a genomic approach[J].Mutation Research,2005,591:224-236.
[34] ALPSOY L,YALVAC M E.Key roles of vitamins A,C,and E in aflatoxin B₁-induced oxidative stress[J].Vitamins & Hormones,2011,86:287-305.
[35] REDDY L,ODHAV B,BHOOLA K,et al.Aflatoxin B₁-induced toxicity in HepG2 cells inhibited by carotenoids:morphology,apoptosis and DNA damage[J].Biological Chemistry,2006,387(1):87-93.
[36] BATCIOGLU K,MEHMET N,OZTUIK I C,et al.Lipid peroxidation and antioxidant status in stomach cancer[J].Cancer Investigation,2006,24(1):18-21.  
[37] BRIGELIUS-FLOHE R.Vitamin E:the shrew waiting to be tamed[J].Free Radical Biology and Medicine,2009,46(5):543-554.  
[38] SAITO K,TAUTZ L,MUSTELIN T.The lipid-binding SEC14 domain[J].Biochimica et Biophysica Acta(BBA):Molecular and Cell Biology of Lipids,2007,1771(6):719-726.  
[39] YANG C S,LAMBERT J D,et al.Antioxidative and anti-carcinogenic activities of tea polyphenols[J].Archives of Toxicology,2009,83(1):11-21.  
[40] SANG S,YANG I,BUCKLEY B,et al.Autoxidative quinine formation in vitro and metabolite formation in vivo from tea polyphenol (-)-epigallocatechin-3-gallate:studied by real-time mass spectrometry combined with tandem mass ion mapping[J].Free Radical Biology & Medicine,2007,43:362-371.
[41] SENTHI-KUMARAN V,ARULMATHI K,SRIVIDHYA R,et al.Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats[J].Experimental Gerontology,2008,43(3):176-183.  
[42] HOU Z,SANG S M,YOU H,et al.Mechanism of action of (-)-epigallocatechin-3-gallate:auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells[J].Cancer Resesrch,2005,65:8049-8056.
[43] YANG C S,LAMBERT J D,JU J,et al.Tea and cancer prevention:molecular mechanisms and human relevance[J].Toxicology and Applied Pharmacology,2007,224(3):265-273.  
[44] TULAYAKUL P,DONG K S,LI J Y,et al.The effect of feeding piglets with the diet containing green tea extracts or coumarin on in vitro metabolism of aflatoxin B₁ by their tissues[J].Toxicon,2007,50(3):339-348.